{"id":345508,"date":"2025-08-25T08:05:12","date_gmt":"2025-08-25T08:05:12","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-avadel-pharmaceuticals\/"},"modified":"2025-08-25T08:05:12","modified_gmt":"2025-08-25T08:05:12","slug":"how-to-buy-avadel-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","title":{"rendered":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-345508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Avadel Pharmaceuticals plc (AVDL) hisselerini mevcut fiyat analizi, 2025-2030 tahminleri ve yeni ba\u015flayanlar i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejileri ile nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Avadel Pharmaceuticals plc (AVDL) hisselerini mevcut fiyat analizi, 2025-2030 tahminleri ve yeni ba\u015flayanlar i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejileri ile nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin."},"intro":"Uyku bozukluklar\u0131 tedavisinde ses getiren bir ila\u00e7 \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Avadel Pharmaceuticals (AVDL), narkolepsi tedavisinde yenilik\u00e7i yakla\u015f\u0131m\u0131yla dikkat \u00e7ekiyor. G\u00fc\u00e7l\u00fc son kazan\u00e7lar ve analist iyimserli\u011fi ile bu hisse, b\u00fcy\u00fcyen uyku ilac\u0131 pazar\u0131na yat\u0131r\u0131m yapmak isteyenler i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Uyku bozukluklar\u0131 tedavisinde ses getiren bir ila\u00e7 \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Avadel Pharmaceuticals (AVDL), narkolepsi tedavisinde yenilik\u00e7i yakla\u015f\u0131m\u0131yla dikkat \u00e7ekiyor. G\u00fc\u00e7l\u00fc son kazan\u00e7lar ve analist iyimserli\u011fi ile bu hisse, b\u00fcy\u00fcyen uyku ilac\u0131 pazar\u0131na yat\u0131r\u0131m yapmak isteyenler i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor."},"body_html":"<h2>\ud83d\udcc8 Avadel Pharmaceuticals Hisse Senedi Analizi: Mevcut Fiyat ve Trendler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Avadel Pharmaceuticals (AVDL) <strong>13,64 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor - bu, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de risk ta\u015f\u0131yan kritik bir seviye. Hisse senedi son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi ve bu t\u00fcr volatilite, bir yat\u0131r\u0131mc\u0131n\u0131n portf\u00f6y\u00fcn\u00fc ya g\u00fc\u00e7lendirebilir ya da zay\u0131flatabilir.<\/p> <p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> - Avadel'in 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bir sonraki \u00f6nemli kataliz\u00f6r tarihi. Tarihsel desenlere g\u00f6re, bu olay hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilir.<\/p> <h3>Son Kazan\u00e7lar\u0131n Etki Analizi<\/h3> <p>\u015eirketin son performans\u0131na bak\u0131ld\u0131\u011f\u0131nda, 7 A\u011fustos 2025 tarihli 2. \u00e7eyrek kazan\u00e7 raporu oyunun seyrini de\u011fi\u015ftirdi. \u015eirket, tahminlerin \u00e7ok \u00fczerinde %233 s\u00fcrprizle <strong>0,10 $ EPS<\/strong> a\u00e7\u0131klad\u0131 (tahminler 0,02-0,03 $ aras\u0131yd\u0131). Gelirler <strong>68,13 milyon $<\/strong> olarak ger\u00e7ekle\u015fti, bu da y\u0131ll\u0131k %64,1 b\u00fcy\u00fcmeyi ve 60,28 milyon $ beklentisini a\u015fmay\u0131 temsil ediyor.<\/p> <p>Bu g\u00fc\u00e7l\u00fc kazan\u00e7 s\u00fcrprizleri Avadel i\u00e7in karakteristik hale geldi. \u00d6nceki \u00e7eyrek (7 May\u0131s 2025, 1. \u00e7eyrek) -0,05 $ EPS ile -0,06 $ beklentisini hafif\u00e7e a\u015ft\u0131. Bu olumlu s\u00fcrprizlerin tutarl\u0131l\u0131\u011f\u0131, y\u00f6netimin b\u00fcy\u00fcme stratejisini etkin \u015fekilde uygulad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3> <p>Avadel hissesi son alt\u0131 ayda dramatik hareketler ya\u015fad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 7,91 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>Mart 2025<\/strong>: 7,83 $ (destek seviyelerinin testi)<\/li> <li><strong>May\u0131s 2025<\/strong>: Yakla\u015f\u0131k 8,00 $ (1. \u00e7eyrek kazan\u00e7 \u00f6ncesi belirsizlik)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 13,64 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 s\u0131\u00e7rama)<\/li> <\/ul> <p>Bu, \u015eubat diplerinden mevcut seviyelere <strong>%72'lik muazzam bir kazan\u00e7<\/strong> anlam\u0131na geliyor. 2. \u00e7eyrek kazan\u00e7 raporu sonras\u0131 ya\u015fanan b\u00fcy\u00fck s\u0131\u00e7rama, ikili olaylar\u0131n ila\u00e7 hisseleri \u00fczerinde ne kadar dramatik etkiler yaratabilece\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist takibi ve piyasa trendlerine dayanarak, Avadel Pharmaceuticals hissesi i\u00e7in beklenenler \u015funlard\u0131r:<\/p> <h3>K\u0131sa Vadeli Tahmin (2025)<\/h3> <p><strong>Mevcut Konsens\u00fcs<\/strong>: Ortalama fiyat hedefi 19,86 $ (y\u00fczde 30 y\u00fckseli\u015f)<br\/> <strong>Aral\u0131k<\/strong>: 12,00 $ - 30,00 $<br\/> <strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL - Son kazan\u00e7 s\u00fcrprizi ve y\u00fckseltilen rehberlik devam eden ivmeyi destekliyor<\/p> <h3>Orta Vadeli Projeksiyonlar<\/h3> <p><strong>2026 Tahmini<\/strong>: 17,60 $-21,00 $ (\u0131l\u0131ml\u0131 b\u00fcy\u00fcme d\u00f6nemi)<br\/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 16,00 $-24,00 $ aral\u0131\u011f\u0131 (konsolidasyon bekleniyor)<br\/> <strong>2030 Vizyonu<\/strong>: 4,68 $-46,18 $ (geni\u015f aral\u0131k d\u00fczenleyici belirsizli\u011fi yans\u0131t\u0131yor)<\/p> <p>Uzun vadeli tahminlerdeki a\u015f\u0131r\u0131 varyans, ila\u00e7 yat\u0131r\u0131mlar\u0131n\u0131n ikili do\u011fas\u0131n\u0131 vurguluyor. \u0130diopatik hipersomni gibi yeni endikasyonlardaki ba\u015far\u0131 fiyatlar\u0131 \u00fcst aral\u0131\u011fa \u00e7ekebilirken, rekabet tehditleri veya d\u00fczenleyici aksakl\u0131klar alt hedeflere do\u011fru itebilir.<\/p> <h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2> <p>Avadel Pharmaceuticals plc (AVDL) hisselerini nas\u0131l alaca\u011f\u0131n\u0131za karar vermeden \u00f6nce, bu kritik riskleri anlay\u0131n:<\/p> <h3>Tek \u00dcr\u00fcn Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/h3> <p>Avadel gelirlerinin %90'\u0131ndan fazlas\u0131n\u0131 sadece LUMRYZ'den elde ediyor. Bu durum \u015fu riskleri yarat\u0131yor:<\/p> <ul> <li>2026 gibi erken bir tarihte beklenen jenerik rekabet<\/li> <li>\u00d6deyici geri \u00f6deme de\u011fi\u015fiklikleri<\/li> <li>Rekabet\u00e7i yeni ila\u00e7 lansmanlar\u0131<\/li> <\/ul> <h3>D\u00fczenleyici Engeller<\/h3> <p>\u015eirketin b\u00fcy\u00fcmesi, idiopatik hipersomni gibi yeni endikasyonlar i\u00e7in FDA onay\u0131na ba\u011fl\u0131. Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 veya d\u00fczenleyici gecikmeler hisseyi ciddi \u015fekilde etkileyebilir.<\/p> <h3>Y\u00fcksek Volatilite<\/h3> <p>Opsiyon piyasalar\u0131, \u00f6zellikle Ocak 2025 25 $ Put opsiyonu i\u00e7in ola\u011fan\u00fcst\u00fc y\u00fcksek implike volatilite g\u00f6steriyor. Bu, yat\u0131r\u0131mc\u0131lar\u0131n fiyat\u0131n her iki y\u00f6nde de \u00f6nemli dalgalanmalar bekledi\u011fini g\u00f6steriyor.<\/p> <h3>Sekt\u00f6r Zorluklar\u0131<\/h3> <p>\u0130la\u00e7 \u015firketleri \u015fu zorluklarla kar\u015f\u0131 kar\u015f\u0131ya:<\/p> <ul> <li>Olas\u0131 devlet fiyat kontrolleri<\/li> <li>\u00d6deyici formulary k\u0131s\u0131tlamalar\u0131<\/li> <li>Artan Ar-Ge maliyetleri<\/li> <\/ul> <h2>\ud83d\udfe2 2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Olumlu Sinyaller<\/h2> <p>Risklere ra\u011fmen, birka\u00e7 fakt\u00f6r y\u00fckseli\u015f g\u00f6r\u00fcn\u00fcm\u00fcn\u00fc destekliyor:<\/p> <h3>G\u00fc\u00e7l\u00fc Finansal Performans<\/h3> <p>2025 2. \u00e7eyrek, Avadel'in <strong>ilk lansman sonras\u0131 karl\u0131l\u0131\u011f\u0131n\u0131<\/strong> 10 milyon $ net gelirle i\u015faret etti. Gelir rehberli\u011fi 2025 i\u00e7in 265-275 milyon $ olarak y\u00fckseltildi, bu da y\u00f6netimin g\u00fcvenini g\u00f6steriyor.<\/p> <h3>Pazar Geni\u015fleme Potansiyeli<\/h3> <p>\u0130diopatik hipersomni i\u00e7in yak\u0131n zamanda al\u0131nan FDA Yetim \u0130la\u00e7 Atamas\u0131, yakla\u015f\u0131k 42.000 potansiyel hasta ile yeni bir pazar a\u00e7\u0131yor. Faz 3 REVITALYZ denemesi 2025 sonunda hasta al\u0131m\u0131n\u0131 tamamlamas\u0131 bekleniyor.<\/p> <h3>Analist Konsens\u00fcs\u00fc<\/h3> <p>7-8 analistin tamam\u0131 AVDL i\u00e7in \"Al\" veya \"G\u00fc\u00e7l\u00fc Al\" derecelendirmesi veriyor, tut veya sat \u00f6nerisi yok. Bu, biyotek sekt\u00f6r\u00fcnde nadir g\u00f6r\u00fclen bir oy birli\u011fi iyimserli\u011fi.<\/p> <h3>B\u00fcy\u00fcyen Hasta Taban\u0131<\/h3> <p>LUMRYZ hasta say\u0131s\u0131 2025 2. \u00e7eyrekte y\u0131ll\u0131k %63 art\u0131\u015f g\u00f6stererek g\u00fc\u00e7l\u00fc ticari benimseme ve hekim kabul\u00fcn\u00fc ortaya koyuyor.<\/p> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p>Avadel Pharmaceuticals plc (AVDL) hisseleri nas\u0131l al\u0131n\u0131r analizime dayanarak, i\u015fte eylem plan\u0131n\u0131z:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> - Y\u00fcksek volatilite nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-3'\u00fcn\u00fc ba\u015flang\u0131\u00e7ta AVDL'ye ay\u0131r\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong> - Tek seferlik b\u00fcy\u00fck al\u0131m yerine, haftal\u0131k veya ayl\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yaparak zamanlama riskini azalt\u0131n<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong> - Giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 i\u00e7in 12 $ (destek) ve 16 $ (diren\u00e7) seviyelerini izleyin<\/li> <li><strong>Kazan\u00e7 Tarihlerini Takip Edin<\/strong> - 11 Kas\u0131m 2025 tarihini takviminize i\u015faretleyin ve rapor \u00f6ncesi pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc azaltmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <\/ol> <p>Esprili t\u00fcccar bilgeli\u011fi: \"AVDL ticareti yapmak, narkolepsi ile uyumaya \u00e7al\u0131\u015fmak gibidir - aniden ya b\u00fcy\u00fck kazan\u00e7larla ya da endi\u015fe verici kay\u0131plarla uyanabilirsiniz. Stop-loss alarmlar\u0131n\u0131z\u0131 kurmak en iyisi!\"<\/p> <h2>\u2705 Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i komisyon oranlar\u0131 sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform i\u015flem \u00f6ncesi kimlik do\u011frulamas\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Volatil hisselerde risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"AVDL\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Volatil piyasalarda giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td><td>Onaylamadan \u00f6nce hisse adedi ve fiyat\u0131 iki kez kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu \u0130zleyin<\/td><td>Fiyat uyar\u0131lar\u0131 kurun ve yat\u0131r\u0131m tezini d\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Neden Yeni AVDL Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Avadel Pharmaceuticals plc (AVDL) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek piyasa ko\u015fullar\u0131nda pratik yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: KYC s\u00fcreci herhangi bir resmi kimlik ile yakla\u015f\u0131k 1 dakika s\u00fcrer<\/li> <li><strong>\u00c7ekim Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve banka transferleri dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: \u0130la\u00e7 hisseleri ara\u015ft\u0131rmas\u0131 i\u00e7in ideal piyasa analizleri ve ticaret ara\u00e7lar\u0131na eri\u015fim<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, Avadel'in volatil hissesiyle stratejileri test etmek i\u00e7in idealdir, b\u00fcy\u00fck miktarlara yat\u0131r\u0131m yapmadan \u00f6nce.<\/p> <h2>\ud83c\udf0d 2025'te Avadel Pharmaceuticals: Uyku \u0130lac\u0131 Yenilik\u00e7isi<\/h2> <p>Avadel Pharmaceuticals, \u00f6zellikle amiral gemisi \u00fcr\u00fcn\u00fc LUMRYZ ile uyku bozukluklar\u0131 tedavisinde lider konumunu sa\u011flamla\u015ft\u0131rd\u0131. Bu gece tek doz oksibat ilac\u0131, narkolepsi hastalar\u0131 i\u00e7in geleneksel \u00e7ok dozlu tedavilere k\u0131yasla \u00f6nemli bir geli\u015fme sunuyor.<\/p> <p>\u015eirketin karl\u0131l\u0131\u011fa ge\u00e7i\u015fi \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131d\u0131r ve ticari stratejilerinin i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6sterir. Geni\u015fleyen sat\u0131\u015f ekipleri ve artan hekim kabul\u00fc ile Avadel, yakla\u015f\u0131k 3 milyar $ de\u011ferindeki k\u00fcresel narkolepsi tedavi pazar\u0131nda iyi bir konumdad\u0131r.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Avadel'in ara\u015ft\u0131rma ekibi, ila\u00e7 da\u011f\u0131t\u0131m sistemlerinin uyku bozukluklar\u0131n\u0131n \u00f6tesinde di\u011fer n\u00f6rolojik hastal\u0131klara da uyarlanabilece\u011fini ke\u015ffetti. Parkinson hastalar\u0131 i\u00e7in modifiye edilmi\u015f bir versiyonu gizlice test ediyorlar - mevcut odaklar\u0131ndan on kat daha b\u00fcy\u00fck potansiyel bir pazar!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Avadel Pharmaceuticals Hisse Senedi Analizi: Mevcut Fiyat ve Trendler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Avadel Pharmaceuticals (AVDL) <strong>13,64 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor &#8211; bu, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de risk ta\u015f\u0131yan kritik bir seviye. Hisse senedi son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi ve bu t\u00fcr volatilite, bir yat\u0131r\u0131mc\u0131n\u0131n portf\u00f6y\u00fcn\u00fc ya g\u00fc\u00e7lendirebilir ya da zay\u0131flatabilir.<\/p>\n<p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> &#8211; Avadel&#8217;in 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bir sonraki \u00f6nemli kataliz\u00f6r tarihi. Tarihsel desenlere g\u00f6re, bu olay hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilir.<\/p>\n<h3>Son Kazan\u00e7lar\u0131n Etki Analizi<\/h3>\n<p>\u015eirketin son performans\u0131na bak\u0131ld\u0131\u011f\u0131nda, 7 A\u011fustos 2025 tarihli 2. \u00e7eyrek kazan\u00e7 raporu oyunun seyrini de\u011fi\u015ftirdi. \u015eirket, tahminlerin \u00e7ok \u00fczerinde %233 s\u00fcrprizle <strong>0,10 $ EPS<\/strong> a\u00e7\u0131klad\u0131 (tahminler 0,02-0,03 $ aras\u0131yd\u0131). Gelirler <strong>68,13 milyon $<\/strong> olarak ger\u00e7ekle\u015fti, bu da y\u0131ll\u0131k %64,1 b\u00fcy\u00fcmeyi ve 60,28 milyon $ beklentisini a\u015fmay\u0131 temsil ediyor.<\/p>\n<p>Bu g\u00fc\u00e7l\u00fc kazan\u00e7 s\u00fcrprizleri Avadel i\u00e7in karakteristik hale geldi. \u00d6nceki \u00e7eyrek (7 May\u0131s 2025, 1. \u00e7eyrek) -0,05 $ EPS ile -0,06 $ beklentisini hafif\u00e7e a\u015ft\u0131. Bu olumlu s\u00fcrprizlerin tutarl\u0131l\u0131\u011f\u0131, y\u00f6netimin b\u00fcy\u00fcme stratejisini etkin \u015fekilde uygulad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3>\n<p>Avadel hissesi son alt\u0131 ayda dramatik hareketler ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 7,91 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Mart 2025<\/strong>: 7,83 $ (destek seviyelerinin testi)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: Yakla\u015f\u0131k 8,00 $ (1. \u00e7eyrek kazan\u00e7 \u00f6ncesi belirsizlik)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 13,64 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 s\u0131\u00e7rama)<\/li>\n<\/ul>\n<p>Bu, \u015eubat diplerinden mevcut seviyelere <strong>%72&#8217;lik muazzam bir kazan\u00e7<\/strong> anlam\u0131na geliyor. 2. \u00e7eyrek kazan\u00e7 raporu sonras\u0131 ya\u015fanan b\u00fcy\u00fck s\u0131\u00e7rama, ikili olaylar\u0131n ila\u00e7 hisseleri \u00fczerinde ne kadar dramatik etkiler yaratabilece\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist takibi ve piyasa trendlerine dayanarak, Avadel Pharmaceuticals hissesi i\u00e7in beklenenler \u015funlard\u0131r:<\/p>\n<h3>K\u0131sa Vadeli Tahmin (2025)<\/h3>\n<p><strong>Mevcut Konsens\u00fcs<\/strong>: Ortalama fiyat hedefi 19,86 $ (y\u00fczde 30 y\u00fckseli\u015f)<br \/> <strong>Aral\u0131k<\/strong>: 12,00 $ &#8211; 30,00 $<br \/> <strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL &#8211; Son kazan\u00e7 s\u00fcrprizi ve y\u00fckseltilen rehberlik devam eden ivmeyi destekliyor<\/p>\n<h3>Orta Vadeli Projeksiyonlar<\/h3>\n<p><strong>2026 Tahmini<\/strong>: 17,60 $-21,00 $ (\u0131l\u0131ml\u0131 b\u00fcy\u00fcme d\u00f6nemi)<br \/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 16,00 $-24,00 $ aral\u0131\u011f\u0131 (konsolidasyon bekleniyor)<br \/> <strong>2030 Vizyonu<\/strong>: 4,68 $-46,18 $ (geni\u015f aral\u0131k d\u00fczenleyici belirsizli\u011fi yans\u0131t\u0131yor)<\/p>\n<p>Uzun vadeli tahminlerdeki a\u015f\u0131r\u0131 varyans, ila\u00e7 yat\u0131r\u0131mlar\u0131n\u0131n ikili do\u011fas\u0131n\u0131 vurguluyor. \u0130diopatik hipersomni gibi yeni endikasyonlardaki ba\u015far\u0131 fiyatlar\u0131 \u00fcst aral\u0131\u011fa \u00e7ekebilirken, rekabet tehditleri veya d\u00fczenleyici aksakl\u0131klar alt hedeflere do\u011fru itebilir.<\/p>\n<h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2>\n<p>Avadel Pharmaceuticals plc (AVDL) hisselerini nas\u0131l alaca\u011f\u0131n\u0131za karar vermeden \u00f6nce, bu kritik riskleri anlay\u0131n:<\/p>\n<h3>Tek \u00dcr\u00fcn Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/h3>\n<p>Avadel gelirlerinin %90&#8217;\u0131ndan fazlas\u0131n\u0131 sadece LUMRYZ&#8217;den elde ediyor. Bu durum \u015fu riskleri yarat\u0131yor:<\/p>\n<ul>\n<li>2026 gibi erken bir tarihte beklenen jenerik rekabet<\/li>\n<li>\u00d6deyici geri \u00f6deme de\u011fi\u015fiklikleri<\/li>\n<li>Rekabet\u00e7i yeni ila\u00e7 lansmanlar\u0131<\/li>\n<\/ul>\n<h3>D\u00fczenleyici Engeller<\/h3>\n<p>\u015eirketin b\u00fcy\u00fcmesi, idiopatik hipersomni gibi yeni endikasyonlar i\u00e7in FDA onay\u0131na ba\u011fl\u0131. Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 veya d\u00fczenleyici gecikmeler hisseyi ciddi \u015fekilde etkileyebilir.<\/p>\n<h3>Y\u00fcksek Volatilite<\/h3>\n<p>Opsiyon piyasalar\u0131, \u00f6zellikle Ocak 2025 25 $ Put opsiyonu i\u00e7in ola\u011fan\u00fcst\u00fc y\u00fcksek implike volatilite g\u00f6steriyor. Bu, yat\u0131r\u0131mc\u0131lar\u0131n fiyat\u0131n her iki y\u00f6nde de \u00f6nemli dalgalanmalar bekledi\u011fini g\u00f6steriyor.<\/p>\n<h3>Sekt\u00f6r Zorluklar\u0131<\/h3>\n<p>\u0130la\u00e7 \u015firketleri \u015fu zorluklarla kar\u015f\u0131 kar\u015f\u0131ya:<\/p>\n<ul>\n<li>Olas\u0131 devlet fiyat kontrolleri<\/li>\n<li>\u00d6deyici formulary k\u0131s\u0131tlamalar\u0131<\/li>\n<li>Artan Ar-Ge maliyetleri<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Olumlu Sinyaller<\/h2>\n<p>Risklere ra\u011fmen, birka\u00e7 fakt\u00f6r y\u00fckseli\u015f g\u00f6r\u00fcn\u00fcm\u00fcn\u00fc destekliyor:<\/p>\n<h3>G\u00fc\u00e7l\u00fc Finansal Performans<\/h3>\n<p>2025 2. \u00e7eyrek, Avadel&#8217;in <strong>ilk lansman sonras\u0131 karl\u0131l\u0131\u011f\u0131n\u0131<\/strong> 10 milyon $ net gelirle i\u015faret etti. Gelir rehberli\u011fi 2025 i\u00e7in 265-275 milyon $ olarak y\u00fckseltildi, bu da y\u00f6netimin g\u00fcvenini g\u00f6steriyor.<\/p>\n<h3>Pazar Geni\u015fleme Potansiyeli<\/h3>\n<p>\u0130diopatik hipersomni i\u00e7in yak\u0131n zamanda al\u0131nan FDA Yetim \u0130la\u00e7 Atamas\u0131, yakla\u015f\u0131k 42.000 potansiyel hasta ile yeni bir pazar a\u00e7\u0131yor. Faz 3 REVITALYZ denemesi 2025 sonunda hasta al\u0131m\u0131n\u0131 tamamlamas\u0131 bekleniyor.<\/p>\n<h3>Analist Konsens\u00fcs\u00fc<\/h3>\n<p>7-8 analistin tamam\u0131 AVDL i\u00e7in &#8220;Al&#8221; veya &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecelendirmesi veriyor, tut veya sat \u00f6nerisi yok. Bu, biyotek sekt\u00f6r\u00fcnde nadir g\u00f6r\u00fclen bir oy birli\u011fi iyimserli\u011fi.<\/p>\n<h3>B\u00fcy\u00fcyen Hasta Taban\u0131<\/h3>\n<p>LUMRYZ hasta say\u0131s\u0131 2025 2. \u00e7eyrekte y\u0131ll\u0131k %63 art\u0131\u015f g\u00f6stererek g\u00fc\u00e7l\u00fc ticari benimseme ve hekim kabul\u00fcn\u00fc ortaya koyuyor.<\/p>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p>Avadel Pharmaceuticals plc (AVDL) hisseleri nas\u0131l al\u0131n\u0131r analizime dayanarak, i\u015fte eylem plan\u0131n\u0131z:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> &#8211; Y\u00fcksek volatilite nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-3&#8217;\u00fcn\u00fc ba\u015flang\u0131\u00e7ta AVDL&#8217;ye ay\u0131r\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong> &#8211; Tek seferlik b\u00fcy\u00fck al\u0131m yerine, haftal\u0131k veya ayl\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yaparak zamanlama riskini azalt\u0131n<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong> &#8211; Giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 i\u00e7in 12 $ (destek) ve 16 $ (diren\u00e7) seviyelerini izleyin<\/li>\n<li><strong>Kazan\u00e7 Tarihlerini Takip Edin<\/strong> &#8211; 11 Kas\u0131m 2025 tarihini takviminize i\u015faretleyin ve rapor \u00f6ncesi pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc azaltmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<\/ol>\n<p>Esprili t\u00fcccar bilgeli\u011fi: &#8220;AVDL ticareti yapmak, narkolepsi ile uyumaya \u00e7al\u0131\u015fmak gibidir &#8211; aniden ya b\u00fcy\u00fck kazan\u00e7larla ya da endi\u015fe verici kay\u0131plarla uyanabilirsiniz. Stop-loss alarmlar\u0131n\u0131z\u0131 kurmak en iyisi!&#8221;<\/p>\n<h2>\u2705 Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i komisyon oranlar\u0131 sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform i\u015flem \u00f6ncesi kimlik do\u011frulamas\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Volatil hisselerde risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;AVDL&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Volatil piyasalarda giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td>\n<td>Onaylamadan \u00f6nce hisse adedi ve fiyat\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu \u0130zleyin<\/td>\n<td>Fiyat uyar\u0131lar\u0131 kurun ve yat\u0131r\u0131m tezini d\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Neden Yeni AVDL Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Avadel Pharmaceuticals plc (AVDL) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek piyasa ko\u015fullar\u0131nda pratik yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: KYC s\u00fcreci herhangi bir resmi kimlik ile yakla\u015f\u0131k 1 dakika s\u00fcrer<\/li>\n<li><strong>\u00c7ekim Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve banka transferleri dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: \u0130la\u00e7 hisseleri ara\u015ft\u0131rmas\u0131 i\u00e7in ideal piyasa analizleri ve ticaret ara\u00e7lar\u0131na eri\u015fim<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, Avadel&#8217;in volatil hissesiyle stratejileri test etmek i\u00e7in idealdir, b\u00fcy\u00fck miktarlara yat\u0131r\u0131m yapmadan \u00f6nce.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Avadel Pharmaceuticals: Uyku \u0130lac\u0131 Yenilik\u00e7isi<\/h2>\n<p>Avadel Pharmaceuticals, \u00f6zellikle amiral gemisi \u00fcr\u00fcn\u00fc LUMRYZ ile uyku bozukluklar\u0131 tedavisinde lider konumunu sa\u011flamla\u015ft\u0131rd\u0131. Bu gece tek doz oksibat ilac\u0131, narkolepsi hastalar\u0131 i\u00e7in geleneksel \u00e7ok dozlu tedavilere k\u0131yasla \u00f6nemli bir geli\u015fme sunuyor.<\/p>\n<p>\u015eirketin karl\u0131l\u0131\u011fa ge\u00e7i\u015fi \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131d\u0131r ve ticari stratejilerinin i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6sterir. Geni\u015fleyen sat\u0131\u015f ekipleri ve artan hekim kabul\u00fc ile Avadel, yakla\u015f\u0131k 3 milyar $ de\u011ferindeki k\u00fcresel narkolepsi tedavi pazar\u0131nda iyi bir konumdad\u0131r.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Avadel&#8217;in ara\u015ft\u0131rma ekibi, ila\u00e7 da\u011f\u0131t\u0131m sistemlerinin uyku bozukluklar\u0131n\u0131n \u00f6tesinde di\u011fer n\u00f6rolojik hastal\u0131klara da uyarlanabilece\u011fini ke\u015ffetti. Parkinson hastalar\u0131 i\u00e7in modifiye edilmi\u015f bir versiyonu gizlice test ediyorlar &#8211; mevcut odaklar\u0131ndan on kat daha b\u00fcy\u00fck potansiyel bir pazar!<\/p>\n"},"faq":[{"question":"Avadel Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AVDL\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin ve pozisyonunuzu izleyin."},{"question":"Avadel Pharmaceuticals'\u0131n ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc LUMRYZ'dir, bu tek dozluk oksibat ilac\u0131 narkolepsi tedavisinde kullan\u0131l\u0131r."},{"question":"Avadel hisselerinin fiyat tahmini nedir?","answer":"2025 i\u00e7in ortalama fiyat hedefi 19,86 $ olup %30 y\u00fckseli\u015f potansiyeli vard\u0131r. Uzun vadede ise 4,68 $ ile 46,18 $ aras\u0131nda geni\u015f bir aral\u0131k \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Avadel Pharmaceuticals yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, d\u00fczenleyici engeller, y\u00fcksek volatilite ve sekt\u00f6r zorluklar\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Avadel hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, ortalama maliyetle al\u0131m yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve kazan\u00e7 tarihlerini takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Avadel Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AVDL\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin ve pozisyonunuzu izleyin."},{"question":"Avadel Pharmaceuticals'\u0131n ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc LUMRYZ'dir, bu tek dozluk oksibat ilac\u0131 narkolepsi tedavisinde kullan\u0131l\u0131r."},{"question":"Avadel hisselerinin fiyat tahmini nedir?","answer":"2025 i\u00e7in ortalama fiyat hedefi 19,86 $ olup %30 y\u00fckseli\u015f potansiyeli vard\u0131r. Uzun vadede ise 4,68 $ ile 46,18 $ aras\u0131nda geni\u015f bir aral\u0131k \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Avadel Pharmaceuticals yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, d\u00fczenleyici engeller, y\u00fcksek volatilite ve sekt\u00f6r zorluklar\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Avadel hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, ortalama maliyetle al\u0131m yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve kazan\u00e7 tarihlerini takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T08:05:12+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T08:05:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\",\"name\":\"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T08:05:12+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T08:05:12+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T08:05:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","name":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T08:05:12+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":345512,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avadel Pharmaceuticals plc (AVDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":345506,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Avadel Pharmaceuticals plc (AVDL) - Investimento em a\u00e7\u00f5es da Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/345508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=345508"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/345508\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=345508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=345508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=345508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}